NDC00075-0200-62: THEOPHYLLINE CAPSULES.
The THEOPHYLLINE CAPSULES is a the manufacturer industrial component. Key specifications include capsule_type: HARD, administration: ORAL, primary_container_type: STRIP, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10, capsule_primary_container_content_quantity: 10.000. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-301-0270, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| capsule_type | HARD |
| administration | ORAL |
| special_features | INDIVIDUALLY SEALED;ACTIVE MEDICAMENT MEDICINAL STRENGTH:200.000 MG ANHYDROUS THEOPHYLLINE ACTIVE INGREDIENT;COATING FEATURE:GELATIN; |
| primary_container_type | STRIP |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| capsule_primary_container_content_quantity | 10.000 |
| NSN | 6505-01-301-0270 |
| ADMINISTRATION | ORAL |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | STRIP |
| SPECIAL FEATURES | INDIVIDUALLY SEALED;ACTIVE MEDICAMENT MEDICINAL STRENGTH:200.000 MG ANHYDROUS THEOPHYLLINE ACTIVE INGREDIENT;COATING FEATURE:GELATIN; |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 10.000 |
| CAPSULE TYPE | HARD |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
No substitute or cross-reference records for this part.